サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：OTC薬の世界市場 (2023年～2032年)：市場規模 (製品・流通チャネル別)・地域別展望・成長の潜在性・競合市場シェア・予測
市場調査レポート
商品コード
1168247

OTC薬の世界市場 (2023年～2032年)：市場規模 (製品・流通チャネル別)・地域別展望・成長の潜在性・競合市場シェア・予測

Over the Counter Drugs Market Size By Product, Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 151 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
OTC薬の世界市場 (2023年～2032年)：市場規模 (製品・流通チャネル別)・地域別展望・成長の潜在性・競合市場シェア・予測
出版日: 2022年12月01日
発行: Global Market Insights Inc.
ページ情報: 英文 151 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

OTC薬の市場は、価格が手頃になってきていることから、2032年にかけて大きく成長すると予想されています。

製品別では、風邪薬・咳止め・インフルエンザ治療薬の部門が2022年に300億米ドル超の収益を記録し、2032年にかけて飛躍的な成長を遂げると予測されています。同部門の成長は、風邪・インフルエンザの発症率の上昇、セルフメディケーション治療に関する意識の高まりなどに起因すると考えられています。また、流通チャネル別では、2032年には病院薬局が27%のシェアを占める見通しです。

当レポートでは、世界のOTC薬の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 OTC薬産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 促進要因
    • 潜在的リスク＆課題
  • 成長性分析
  • COVID-19影響分析
  • 規制状況
  • ポーターの分析
  • PESTLE分析

第4章 競合情勢

  • 企業マトリックス分析
  • 戦略ダッシュボード

第5章 OTC薬市場：製品別

  • 主要動向
  • 鎮痛剤
  • 風邪薬・咳止め・インフルエンザ治療薬
  • 減量製品
  • 胃腸製品
  • 肌用製品
  • ミネラル・ビタミンサプリメント
  • 睡眠補助剤
  • 眼科製品
  • その他

第6章 OTC薬市場：流通チャネル別

  • 主要動向
  • 病院薬局
  • 小売薬局
  • オンライン医療品店
  • その他

第7章 OTC薬市場：地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • Bayer AG.
  • GlaxoSmithKline（GSK）.
  • Sanofi
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Alkem Laboratories Limited
  • Cipla, Inc
  • Reckitt Benckiser Group Plc.
  • Piramal Enterprises Limited
  • Teva Pharmaceutical Industries Ltd
  • Glenmark Pharmaceuticals Ltd
  • The Blackstone Group, Inc.（Alinamin Pharmaceutical Co., Ltd.）
  • Aytu Biopharma, Inc.（Aytu Consumer Health, Inc.）
  • Dr. Reddy's Laboratories
  • Viatris, Inc.（Mylan, Inc.）
図表

Data Tables

  • TABLE 1 Global OTC drugs market, 2018 - 2022 (USD Million)
  • TABLE 2 Global OTC drugs market, 2023 - 2032 (USD Million)
  • TABLE 3 Global OTC drugs market, by product, 2018 - 2022 (USD Million)
  • TABLE 4 Global OTC drugs market, by product, 2023 - 2032 (USD Million)
  • TABLE 5 Global OTC drugs market, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 6 Global OTC drugs market, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 7 Global OTC drugs market, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global OTC drugs market, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Industry impact forces
  • TABLE 10 Analgesics market size, by region, 2018 - 2022 (USD Million)
  • TABLE 11 Analgesics market size, by region, 2023 - 2032 (USD Million)
  • TABLE 12 Cold, cough and flu products market size, by region, 2018 - 2022 (USD Million)
  • TABLE 13 Cold, cough and flu products market size, by region, 2023 - 2032 (USD Million)
  • TABLE 14 Weight loss products market size, by region, 2018 - 2022 (USD Million)
  • TABLE 15 Weight loss products market size, by region, 2023 - 2032 (USD Million)
  • TABLE 16 Gastrointestinal products market size, by region, 2018 - 2022 (USD Million)
  • TABLE 17 Gastrointestinal products market size, by region, 2023 - 2032 (USD Million)
  • TABLE 18 Skin products market size, by region, 2018 - 2022 (USD Million)
  • TABLE 19 Skin products market size, by region, 2023 - 2032 (USD Million)
  • TABLE 20 Minerals and vitamin market size, by region, 2018 - 2022 (USD Million)
  • TABLE 21 Minerals and vitamin market size, by region, 2023 - 2032 (USD Million)
  • TABLE 22 Sleeping aids market size, by region, 2018 - 2022 (USD Million)
  • TABLE 23 Sleeping aids market size, by region, 2023 - 2032 (USD Million)
  • TABLE 24 Ophthalmic products market size, by region, 2018 - 2022 (USD Million)
  • TABLE 25 Ophthalmic products market size, by region, 2023 - 2032 (USD Million)
  • TABLE 26 Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 27 Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 28 Hospital pharmacy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 29 Hospital pharmacy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 30 Retail pharmacy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 31 Retail pharmacymarket size, by region, 2023 - 2032 (USD Million)
  • TABLE 32 Online medstores market size, by region, 2018 - 2022 (USD Million)
  • TABLE 33 Online medstores market size, by region, 2023 - 2032 (USD Million)
  • TABLE 34 Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 35 Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 36 North America OTC drugs market size, by country, 2018 - 2022 (USD Million)
  • TABLE 37 North America OTC drugs market size, by country, 2023 - 2032 (USD Million)
  • TABLE 38 North America OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 39 North America OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 40 North America OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 41 North America OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 42 U.S. OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 43 U.S. OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 44 U.S. OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 45 U.S. OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 46 Canada OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 47 Canada OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 48 Canada OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 49 Canada OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 50 Europe OTC drugs market size, by country, 2018 - 2022 (USD Million)
  • TABLE 51 Europe OTC drugs market size, by country, 2023 - 2032 (USD Million)
  • TABLE 52 Europe OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 53 Europe OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 54 Europe OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 55 Europe OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 56 Germany OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 57 Germany OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 58 Germany OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 59 Germany OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 60 UK OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 61 UK OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 62 UK OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 63 UK OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 64 France OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 65 France OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 66 France OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 67 France OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 68 Italy OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 69 Italy OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 70 Italy OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 71 Italy OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 72 Spain OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 73 Spain OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 74 Spain OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 75 Spain OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 76 Russia OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 77 Russia OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 78 Russia OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 79 Russia OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 80 Poland OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 81 Poland OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 82 Poland OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 83 Poland OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 84 Asia Pacific OTC drugs market size, by country, 2018 - 2022 (USD Million)
  • TABLE 85 Asia Pacific OTC drugs market size, by country, 2023 - 2032 (USD Million)
  • TABLE 86 Asia Pacific OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 87 Asia Pacific OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 88 Asia Pacific OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 89 Asia Pacific OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 90 India OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 91 India OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 92 India OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 93 India OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 94 China OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 95 China OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 96 China OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 97 China OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 98 Japan OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 99 Japan OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 100 Japan OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 101 Japan OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 102 Australia OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 103 Australia OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 104 Australia OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 105 Australia OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 106 South Korea OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 107 South Korea OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 108 South Korea OTC drugs market size, by distribtion channel, 2018 - 2022 (USD Million)
  • TABLE 109 South Korea OTC drugs market size, by distribtion channel, 2023 - 2032 (USD Million)
  • TABLE 110 Taiwan OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 111 Taiwan OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 112 Taiwan OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 113 Taiwan OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 114 Latin America OTC drugs market size, by country, 2018 - 2022 (USD Million)
  • TABLE 115 Latin America OTC drugs market size, by country, 2023 - 2032 (USD Million)
  • TABLE 116 Latin America OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 117 Latin America OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 118 Latin America OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 119 Latin America OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 120 Brazil OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 121 Brazil OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 122 Brazil OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 123 Brazil OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 124 Mexico OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 125 Mexico OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 126 Mexico OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 127 Mexico OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 128 Argentina OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 129 Argentina OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 130 Argentina OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 131 Argentina OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 132 MEA OTC drugs market size, by country, 2018 - 2022 (USD Million)
  • TABLE 133 MEA OTC drugs market size, by country, 2023 - 2032 (USD Million)
  • TABLE 134 MEA OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 135 MEA OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 136 MEA OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 137 MEA OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 138 South Africa OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 139 South Africa OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 140 South Africa OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 141 South Africa OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 142 Saudi Arabia OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 143 Saudi Arabia OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 144 Saudi Arabia OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 145 Saudi Arabia OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 146 Kuwait OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 147 Kuwait OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 148 Kuwait OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 149 Kuwait OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 150 Qatar OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 151 Qatar OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 152 Qatar OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 153 Qatar OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 154 Nigeria OTC drugs market size, by product, 2018 - 2022 (USD Million)
  • TABLE 155 Nigeria OTC drugs market size, by product, 2023 - 2032 (USD Million)
  • TABLE 156 Nigeria OTC drugs market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 157 Nigeria OTC drugs market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 OTC drugs industry 360 degree synopsis, 2018 - 2032
  • FIG. 2 Industry segmentation
  • FIG. 3 Global OTC drugs market, 2018 - 2032 (USD Million)
  • FIG. 4 Growth potential analysis, by product
  • FIG. 5 Growth potential analysis, by distribution channel
  • FIG. 6 Porter's analysis
  • FIG. 7 PESTEL analysis
  • FIG. 8 Company matrix analysis, 2021
  • FIG. 9 Strategy dashboard, 2021
  • FIG. 10 Key segment trends, by product
  • FIG. 11 Key segment trends, by distribution channel
  • FIG. 12 Key regional trends
目次
Product Code: 1884

Over the Counter (OTC) Drugs Market is slated to witness massive growth through 2032, mainly owing to the increasing affordability of OTC drugs for both the consumers as well as for the healthcare system across the globe.

In addition, Rx to OTC switch results in greater availability and sales due to easy off-the-shelf availability, better accessibility, and cost-effectiveness.

Several key players operating in the over the counter (OTC) drugs market are incorporating strategic initiatives like acquisitions, mergers, and product developments to strengthen their foothold in the industry.

For instance, in May 2022, Bayer Healthcare entered into a partnership agreement with Alibaba Health to promote and distribute consumer health products and solutions. This supported the firm expand its capabilities and market share in the industry.

Overall, the over the counter (OTC) drugs market is bifurcated in terms of product, distribution channel, and regional landscape.

By product, the cold, cough & flu products segment recorded a revenue of more than USD 30 billion in 2022 and is poised to grow exponentially by 2032. The segmental growth will be attributed to the rising incidence of cold & flu among the population and increased awareness and preferences about self-medication treatment.

The skin products segment is also expected to register strong growth by 2032, owing to consumers' rising inclination and preference towards several beauty products such as serums, creams, and moisturizers. In addition, rising consciousness regarding one's physical appearance, especially among the female population, will further push the segment's growth.

By distribution channel, the hospital pharmacy segment is expected to account for 27% market share by 2032. Hospital pharmacy offers better patient counseling for authentic products. Along with this, the availability of various products in the market will propel the segment share in the coming future.

Considering the regional perspective, the North America over the counter (OTC) drugs market held a substantial market share of more than 25% in 2022 and is predicted to grow significantly through 2032. The regional growth will be attributed to the rising acceptance of OTC drugs by consumers in the North American economies combined with the established regulatory authorities.

Some of the key players operating in the market are Johnson & Johnson Services Inc., GlaxoSmithKline Plc., Bayer AG, Sanofi, The Blackstone Group, Inc. (Alinamin Pharmaceutical Co., Ltd.), Piramal Enterprises Limited, Sun Pharmaceutical Industries Ltd., Cipla, Inc., Alkem Laboratories Limited., Reckitt Benckiser Group Plc., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., and Dr. Reddy's Laboratories, Viatris, Inc.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definations
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia pacific
    • 1.2.4 Latin America
    • 1.2.5 MEA
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Over the counter (OTC) drugs market industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Distribution channel trends
    • 2.1.4 Regional trends

Chapter 3 Over the Counter (OTC) Drugs Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Pharmaceutical companies switching from Rx to OTC drugs especially in the U.S
      • 3.3.1.2 Growing trend of self-medication in developing economies
      • 3.3.1.3 Significant cost savings due to OTC drug usage in Asia Pacific and Latin America
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Several concerns pertaining to incorrect diagnosis and substance abuse
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By distribution channel
  • 3.5 COVID- 19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Porter's analysis
    • 3.7.1 Bargaining power of suppliers
    • 3.7.2 Bargaining power of buyers
    • 3.7.3 Threat of new entrants
    • 3.7.4 Threat of substitutes
    • 3.7.5 Industry rivalry
  • 3.8 PESTLE analysis
    • 3.8.1 Political
    • 3.8.2 Economical
    • 3.8.3 Social
    • 3.8.4 Technological
    • 3.8.5 Legal
    • 3.8.6 Environmental

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
    • 4.1.1 Company 1
    • 4.1.2 Company 2
    • 4.1.3 Company 3
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Over the Counter (OTC) Drugs Market, By Product

  • 5.1 Key segment trends
  • 5.2 Analgesics
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.3 Cold, cough & flu products
    • 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.4 Weight loss products
    • 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.5 Gastrointestinal products
    • 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.6 Skin products
    • 5.6.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.7 Minerals and vitamin supplements
    • 5.7.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.8 Sleeping aids
    • 5.8.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.9 Ophthalmic products
    • 5.9.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.10 Others
    • 5.10.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Over the Counter (OTC) Drugs Market, By Distribution Channel

  • 6.1 Key segment trends
  • 6.2 Hospital pharmacy
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 Retail pharmacy
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.4 Online medstores
    • 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.5 Others
    • 6.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Over the Counter (OTC) Drugs Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.2.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.2.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.2.4 U.S.
      • 7.2.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.2.5 Canada
      • 7.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.3.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.3.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.3.4 Germany
      • 7.3.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.3.5 UK
      • 7.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.3.6 France
      • 7.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.3.7 Italy
      • 7.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.7.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.8.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.3.9 Russia
      • 7.3.9.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.9.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.3.10 Poland
      • 7.3.10.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.10.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.4.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.4.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.4.4 China
      • 7.4.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.4.6 India
      • 7.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.4.7 Australia
      • 7.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.7.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.4.8 South Korea
      • 7.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.8.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.4.9 Taiwan
      • 7.4.9.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.9.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.5.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.5.4 Brazil
      • 7.5.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.5.5 Mexico
      • 7.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.5.6 Argentina
      • 7.5.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.6.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.6.4 South Africa
      • 7.6.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.6.5 Saudi Arabia
      • 7.6.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.6.6 Qatar
      • 7.6.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.6.7 Nigeria
      • 7.6.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.7.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
    • 7.6.8 Kuwait
      • 7.6.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.8.2 Market size, by distribution channel, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Bayer AG.
    • 8.1.1 Business overview
    • 8.1.2 Financial data
    • 8.1.3 Product landscape
    • 8.1.4 Strategic outlook
    • 8.1.5 SWOT analysis
  • 8.2 GlaxoSmithKline (GSK).
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Sanofi
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Johnson & Johnson
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Sun Pharmaceutical Industries Ltd
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Alkem Laboratories Limited
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Cipla, Inc
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Reckitt Benckiser Group Plc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Piramal Enterprises Limited
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Teva Pharmaceutical Industries Ltd
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Glenmark Pharmaceuticals Ltd
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 The Blackstone Group, Inc. (Alinamin Pharmaceutical Co., Ltd.)
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Aytu Biopharma, Inc. (Aytu Consumer Health, Inc.)
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Dr. Reddy's Laboratories
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Viatris, Inc. (Mylan, Inc.)
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Product landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis